ClinicalTrials.gov
ClinicalTrials.gov Menu

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00727727
Recruitment Status : Completed
First Posted : August 4, 2008
Last Update Posted : February 25, 2009
Sponsor:
Information provided by:
Desitin Arzneimittel GmbH